Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 1;10(12):4151-4164.
eCollection 2020.

Management of nephrotoxicity of chemotherapy and targeted agents: 2020

Affiliations
Review

Management of nephrotoxicity of chemotherapy and targeted agents: 2020

Varsha Chiruvella et al. Am J Cancer Res. .

Abstract

Nephrotoxic effects of certain chemotherapeutic agents such as cisplatin and ifosfamide has been well documented and these effects are carefully managed by oncologists during their usage. The introduction of targeted agents has added a new challenge to cancer management as their nephrotoxic effects and associated management is in the process of being adopted by oncologists. This work is a compilation of side effects on the renal system due to various chemotherapeutic, immunotherapeutic and targeted agents followed by their recommended management.

Keywords: Nephrotoxicity; acute kidney injury; chronic kidney disease; side effects; tumor lysis syndrome.

PubMed Disclaimer

Conflict of interest statement

None.

Similar articles

Cited by

References

    1. Perazella MA, Shirali AC. Nephrotoxicity of cancer immunotherapies: past, present and future. J Am Soc Nephrol. 2018;29:2039–2052. - PMC - PubMed
    1. Perazella MA. Onco-nephrology: renal toxicities of chemotherapeutic agents. Clin J Am Soc Nephrol. 2012;7:1713–1721. - PubMed
    1. Santos MLC, de Brito BB, da Silva FAF, Botelho ACDS, de Melo FF. Nephrotoxicity in cancer treatment: an overview. World J Clin Oncol. 2020;11:190–204. - PMC - PubMed
    1. Naughton CA. Drug-induced nephrotoxicity. Am Fam Physician. 2008;78:743–750. - PubMed
    1. Malyszko J, Kozlowska K, Kozlowski L, Malyszko J. Nephrotoxicity of anticancer treatment. Nephrol Dial Transplant. 2017;32:924–936. - PubMed

LinkOut - more resources